Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Memphis, TN, USA.
Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Memphis, TN, USA; OB/GYN, University of Tennessee Health Science Center, Memphis, TN, USA.
Resuscitation. 2017 Jun;115:1-4. doi: 10.1016/j.resuscitation.2017.03.009. Epub 2017 Mar 18.
Delivery room resuscitation of very low birth weight infants can involve use of endotracheal or intravenous epinephrine. Data of the past 19 years were reviewed to identify the usage of epinephrine in delivery room and identify characteristics of these babies.
Neonates with ≤1500g birthweight from January 1996 to August 2014 were reviewed. Infants born alive and admitted to NICU were eligible. Characteristics such as demographics, survival and outcomes were recorded. Variables significant at p≤0.1 among neonates receiving epinephrine were further analyzed via multiple logistic regressions.
Out of 5868 eligible neonates, 416 (7%) received epinephrine in the delivery room. The infants who received epinephrine were of lower estimated gestational age (25 vs. 28wk) and lower birth weight (746 vs. 980g). Gender, race and mode of delivery were comparable between the two cohorts. Survival was higher in non-epinephrine group (89.4 vs. 61.1%). Bacterial infection (24.3 vs. 18.4%) and combined grade 3 and 4 intraventricular hemorrhage (18.4 vs. 8.4%) were higher in epinephrine group. Use of epinephrine in the delivery room was associated with decreased survival even after controlling for birth weight, gestational age and low Apgar scores [Odd ratio - 0.48 with 95% CI (0.37-0.62), p<0.001].
Neonates with lower birth weight and younger gestational age were more likely to receive epinephrine during resuscitation at birth. Use of epinephrine in delivery room was associated with lower survival and severe intraventricular hemorrhage among very low birth weight infants.
极低出生体重儿的产房复苏可能需要使用气管内或静脉内肾上腺素。回顾过去 19 年的数据,以确定产房中肾上腺素的使用情况,并确定这些婴儿的特征。
回顾了 1996 年 1 月至 2014 年 8 月出生体重≤1500g 的新生儿。符合条件的为出生后存活并收入新生儿重症监护病房的婴儿。记录了人口统计学特征、存活和结局等特征。对接受肾上腺素的新生儿中 p≤0.1 的变量进行了进一步的多变量逻辑回归分析。
在 5868 名合格的新生儿中,有 416 名(7%)在产房接受了肾上腺素。接受肾上腺素的婴儿胎龄(25 周与 28 周)和出生体重(746g 与 980g)较低。两组之间的性别、种族和分娩方式相似。非肾上腺素组的存活率更高(89.4%与 61.1%)。细菌感染(24.3%与 18.4%)和合并 3 级和 4 级脑室内出血(18.4%与 8.4%)在肾上腺素组中更高。即使在控制出生体重、胎龄和低 Apgar 评分后,产房中使用肾上腺素与存活率降低相关[比值比为 0.48,95%置信区间为(0.37-0.62),p<0.001]。
出生体重较低和胎龄较小的新生儿在复苏时更有可能接受肾上腺素。极低出生体重儿在产房中使用肾上腺素与存活率降低和严重脑室内出血有关。